SEARCH

SEARCH BY CITATION

Keywords:

  • history of cancer;
  • history of surgical oncology;
  • history of neurosurgery;
  • history of diagnostic radiology and radiation therapy;
  • history of surgical pathology;
  • history of cancer research;
  • history of cancer epidemiology and statistics;
  • history of cancer societies and cancer institutions

Abstract

  1. Top of page
  2. Abstract
  3. FUNDING SOURCES
  4. REFERENCES

In the 3 decades from 1910 to 1940, more progress took place in cancer research and the diagnosis and treatment of cancers than during the prior centuries combined. The discovery of several carcinogens, precancerous conditions, and hereditary cancers adduced new thoughts about the genesis of cancers. Even though diagnostic radiology and radiation therapy became apposite specialties, surgery retained its primacy in the treatment of cancer patients. The delineation of new and distinct neoplastic entities, several precancerous lesions, and noninvasive carcinomas as well as the introduction of histopathologic grading of cancers promulgated cogent changes in therapy. Yet, with all the advances in the diagnosis and treatment of cancers, very little betterment could be demonstrated in the overall survival of patients, and by the end of the 1930s, cancer became the second most common cause of death in the United States. Cancer 2013. © 2012 American Cancer Society.

The 3 decades from 1910 to 1940 were the formative years of cancer research in the experimental and clinical laboratories, medical clinics, surgical theaters, and radiology suites. Researchers in the basic sciences and clinical practice disabused fallacious hoary hypotheses that cancer was caused by, inter alia, demons, moral and religious deviations, and humoral imbalances. The initiative of Payton Rous (1879-1970) of using hens for cancer research,1 and the experimental demonstration by Theodor Boveri (1862-1915) that cancer can be triggered by chromosomal mutation,2 galvanized widespread use of animals in the research laboratories.

A few years after the first person, a radiology technician, died of cancer of the skin which was caused by years of exposure to incidental radiation by x-rays,1 Pierre Marie (1853-1940) of France succeeded in producing skin cancer in rats by using x-rays.3 Alexis Carrel (1873-1944) and Montrose T. Burrows (1884-1947) of the Rockefeller Institute for Medical Research in New York established a tissue culture laboratory and were the first to grow tumor tissue in vitro. They used extract from the Rous chicken sarcoma.4 Four years later, at the same institution, the first human cancer, an osteosarcoma, was grown in tissue culture5 (Fig. 1). After refinements of the tissue culture techniques, it was demonstrated that the accurate analysis of the microscopic differences between normal and malignant cells is feasible in tissue culture.6 Eventually, this observation lead to studies, in the 1930s and 1940s, of hundreds of human cancers in long-term tissue cultures.

thumbnail image

Figure 1. This photomicrograph, published in 1914, illustrates the first tissue culture of a human cancer, an osteosarcoma.5

Download figure to PowerPoint

Carrel, in collaboration with the American aviator Charles Lindbergh (1902-1974), advanced the in vitro techniques by designing a pump for perfusion of cancer-containing animal and human organs with oxygenated nutrient fluid. They demonstrated that the perfused organs and cancers maintained their preperfusion morphology.7 The prerequisite of oxygen for the maintenance of tissues was delineated for the first time by Otto H. Warburg (1883-1970), a German biochemist. He evinced by laboratory experiments that when oxygenation of tissue cells is irreversibly damaged and too little adenosine triphosphate is formed, the increase in fermentation may lead to the production of cancer.8 Subsequently, he discovered that cancer cells use glucose at a higher rate than normal tissues, a phenomenon remembered as the Warburg effect. The Warburg effect realized its full use 50 years later, as the principle behind positron emission tomography (ie, the PET scan). Warburg received the Nobel Prize in 1931 for fruition of his work in biochemistry.

The hypothesis that parasites were cancer-causing organisms was propagated by Johannes Fibiger (1867-1928), a Danish pathologist. He claimed that he produced gastric carcinoma in rats by feeding them cockroaches infected with parasitic nematodes, Spiroptera.9 Fibiger was awarded the Nobel Prize for his work in 1926. Years later, his reputation was tarnished because researchers failed to corroborate his results.

Katsusaburo Yamagiwa (1863-1930), a Tokyo pathologist, first performed a now time-honored experiment, by succeeding to cause tar cancer in animals. For 2 years, Yamagiwa and his associates painted daily the ears of rabbits with a solution of crude coal tar and produced invasive skin cancer in 7 of 137 rabbits. In 2 of these rabbits, the carcinoma metastasized to regional lymph nodes.10 After Yamagiwa's success, the tar-painting of animals became the favorite experimental method for inducing cancer. Researchers decried, for example, that injection of urethane into rabbits and rats was followed by decrease in the circulating lymphocytes11 (Fig. 2). This finding prefigured chemotherapeutic application of urethane in leukemia. More than a decade later, it was demonstrated in a series of experimental studies that by adding mustard gas to coal tar, the carcinogenic effect of tar was inhibited.12 After this germane discovery, nitrogen mustard was added to urethane as a new chemotherapeutic agent.

thumbnail image

Figure 2. The first page is shown of James A. Hawkins' and James B. Murphy's original article11 on a newly discovered chemotherapeutic agent, urethane.

Download figure to PowerPoint

In 1930, Ernest L. Kennaway (1881-1958), of London, and his team of researchers isolated polycyclic hydrocarbons from coal tar and identified them as carcinogens in experimental animals.13 Two years later, 3,4-benzopyrene was also recovered from coal tar and was added to the list of active carcinogens.14 These nascent discoveries were followed by identification of several additional carcinogens in tars, industrial oils, and petroleum.15-17 The majority of the compounds produced cancer in the liver, kidney, lung, and breast of laboratory animals. After a decade of intensive research activity, hundreds of experimental carcinogens were identified.18, 19

The search for carcinogens extended intuitively to naturally occurring hormones, and in 1932, Antoine M. Lacassagne (1884-1971), a French physician, discovered that carcinoma of the breast can be induced by a female sex hormone (estrogen) injections in male mice.20 A few years later, Lacassagne's original experiment was confirmed by injection of estrogenic compounds into male and female mice.21 The theory was then introduced that the same normally occurring endogenous ovarian hormones, estrogen and progesterone, may play role in the development of breast carcinoma in humans.22 At this point, the notion was advanced whether breast cancer patients would benefit from hormonal antagonists23 (Fig. 3). Using endogenous hormones, Charles B. Huggins (1901-1997), a maverick American urologist, and his coterie of researchers demonstrated experimentally the dependency of prostatic hyperplasia and carcinoma on naturally occurring hormones.24 They proved that carcinoma of the prostate was stimulated by androgens and inhibited by female sex hormones. Not long after their discovery, Huggins began the treatment of carcinoma of the prostate with hormonal manipulation and castration.25 For his pioneering treatment of prostate carcinoma, Huggins received the Nobel Prize in 1966.

thumbnail image

Figure 3. The first page is shown of Antoine M. Lacassagne's article23 in which he introduced the concept that breast cancer patients would benefit from anti-estrogen therapy.

Download figure to PowerPoint

Viral research slowed dramatically in the 1920s and 1930s, and there were only 2 memorable original observations reported. Richard E. Shope (1901-1966), an American physician, working at the Rockefeller Institute in New York where Payton Rous made his discovery 2 decades earlier,1 identified a filterable virus which is capable of causing cancerous skin papillomas, a naturally occurring disease called infectious papillomatosis of rabbits. The virus is now known to be a pox virus. Shope was able to transmit the papillomas to other rabbits by rubbing the filtrate on the scarified skin.26 Another disease of infectious nature, Jaagsiekte disease (running sickness of sheep) was reported in South Africa and Australia.27 Because Jaagsiekte disease was transmitted from one animal to another by direct contact, a viral etiology was suspected. Three decades later, the virus was identified as a retrovirus. The striking macroscopic and microscopic similarity of pulmonary changes in Jaagsiekte disease in sheep to bronchioloalveolar carcinoma of the lung in humans has been demonstrated28 (Fig. 4), and is of particular interest at present concerning the epidemiology of lung cancers.29 An erudite reflection on tumor-causing viruses was published by Payton Rous in 1936. He prophetically predicted that some of the viruses may play pivotal role as initiators of carcinogenesis in animals and humans.30

thumbnail image

Figure 4. The first page is shown of the article by C. Bonne28 in which he demonstrated the morphologic similarity of pulmonary adenomatosis in sheep, a viral disease, and bronchioloalveolar carcinoma in humans.

Download figure to PowerPoint

Simultaneously with the aforementioned events in cancer research, multifarious inquires took place in the refinement of thoughts on the etiology and causation of cancers in humans. Twenty-two years after the initial report that Schistosoma hematobium may cause bladder tumor,1 the association between bilharziasis and carcinoma of the bladder was incontrovertibly established in a series of patients upon postmortem examination.31

It had been known for decades that miners in the European Erz Mountains were dying of lung cancer,1 but it was not discovered until 1932 that the miners' lung cancers were due to inhalation of dust containing radium and other radioactive substances.32 A report appeared, almost simultaneously with the European study, that osteosarcoma occurred in workers of a watch factory in New Jersey in the United States, from use of paint containing radium and mesothorium.33 After these reports, radium was added alongside x-ray as a potential carcinogen.

A gamut of veritable observations linked certain cancers to preexisting conditions, inter alia, gastric carcinoma to ulcer of the stomach,34 achlorohydria,35 and chronic gastritis36; linitis plastica to sclerosing degeneration of submucosal gastric glands37; squamous carcinoma of the tongue to leukoplakia38; carcinoid to hyperplasia of the ubiquitous enterochromaffin cells39; skin cancer to kangri basket burn40 and burn scar41; mucosal and cutaneous cancers to inflammatory, mechanical, and chemical irritations42-44; melanoma to traumatized nevi45; malignant tumors of the thyroid to goiters46; colon cancer to ulcerative colitis,47 and hereditary48 and nonhereditary polyposis49; liver carcinoma to cirrhosis and hemochromatosis of the liver35; osteosarcoma to Paget's disease of bone50; and lung carcinoma to squamous metaplasia of the bronchial mucosa.51 Six years after the discovery of asbestos bodies in pulmonary and pleural nodules of asbestos workers,52 it was demonstrated that some of the pulmonary carcinomas and pleural mesotheliomas are caused by asbestosis.53

Tobacco was recognized as a potentially harmful product shortly after it was imported to Europe from Central America in the 1500s. The saga of the danger of smoking is a long one,54 and in 1928, it was definitively established that excessive smoking causes cancer of the lip, jaw, cheek, and the tongue.55 Abstinence from smoking was advised to persons with sores of the oral mucosa, buccal leukoplakia, laryngeal lesions, and chronic bronchitis.56 Frederick L. Hoffman, a statistician of the Prudential Insurance Company of America, performed a survey in the 1920s to see whether there were any health problems associated with tobacco smoking.57 He analyzed his cases with consideration of the kind of tobacco used, the method of smoking, the quantity smoked, and the age at which the person had begun to smoke. He found that the increase in cancer of the lung was directly traceable to cigarette smoking, but older methods of smoking, such as pipe and cigar, were more injurious than the smoking of cigarettes. In Germany, it was demonstrated that of 86 men with lung cancer, the percent of heavy and moderate smokers and nonsmokers were 65%, 48%, and 16%, respectively.58

After reviewing potential etiologic agents from bacteria and chemicals to tobacco, it was concluded51 that external injury by inhalation and intrinsic predisposition of bronchial epithelial cells were the principal causes of lung cancer. In 1941, it was observed by 2 American thoracic surgeons that the increase in lung cancer was due to the increased consumption of tobacco and production of automobiles.59 They admitted the gravity of pulmonary cancer but they believed that due to early detection and advances in surgical therapy, the prognosis was becoming relatively favorable. It is perhaps apt to add that in the interim, Wendell M. Stanly (1905-1971), an American chemist, working in Princeton, New Jersey, isolated the tobacco mosaic virus from infected tobacco leaves.60 In recognition of his work, he received the Nobel Prize in 1946.

The heredity of cancer was debated for centuries,1 but the first credible report of the aggregation of cancer in one family was reported in 1913.61 More than a decade later, 13 members of a family of 30 individuals were reported to have polyposis of the colon.62 In 5 of the patients, the polyps progressed to carcinoma. Carcinoma of the ovary in twins was also published.63 Despite these and other sporadic reports of the occurrence of cancer of the breast, uterus, and prostate in certain families, the genetic nature of cancer remained belittled through the 1940s.

Pathologists in the early 1900s emerged from the autopsy rooms and became the helping hands and the microscopic eyes of surgeons and other physicians. The most noted surgical pathologists were James Ewing (1866-1943) of the United States, Pierre Masson (1880-1959) of France-Canada, and Albert C. Broders (1885-1964) of the United States.

James Ewing, a hematopathologist by background, became the first pathologist in 1913 at the Memorial Hospital for the Treatment of Cancer and Allied Diseases in New York City.1 Being the sole pathologist at the only cancer hospital in the United States afforded him the case material and daily contact with the radiologists, surgeons, and other physicians who cared for cancer patients. Thus, in addition to being a peerless tumor pathologist, he became an adroit clinical oncologist and diagnostic radiologist. Ewing was a polyglot and well-read. In 1919, his book, Neoplastic Diseases, a seminal text on tumors was published and fast became the standard text for the diagnosis and treatment of tumors64 (Fig. 5). It is a massive tome with 1027 pages, nearly 500 clinical and microscopic photographs, and more than 3000 references. After the introductory chapters, there are 39 chapters on specific oncologic entities and organs with tumors. Ewing's book went through 3 subsequent editions. Each updated and enlarged edition was viewed as the most authoritative work on the diagnosis, treatment, and natural history of benign and malignant tumors. The last edition was printed in 1940.65 Ewing summarized in his books his experience and all that was known about tumors. He had a profound interest in the genesis and the etiology of cancers, and believed that inflammation caused by an endless number of chemicals and other tissue-damaging agents was the main cause of cancers. The transformation of benign tumors to malignant ones is a recurring topic in all his writings. Ewing was an advocate of early diagnosis of cancer by radiologic and clinical examination of patients, and microscopic study of minute tissue fragments which were obtained by biopsy forceps, cutting needle, or needle aspiration.64, 65

thumbnail image

Figure 5. Shown is the title page of the first edition of James Ewing's authoritative text64 on the diagnosis and treatment of malignant tumors.

Download figure to PowerPoint

In 1921, Ewing reported the clinical, radiologic, and pathologic features of a rare and deadly bone cancer in 7 youngsters.66 He named the tumor “diffuse endothelioma,” which has since become known as Ewing's sarcoma.

Shortly after Ewing was appointed as chief of pathology, he became director of the cancer hospital, a position he held until 1939. Ewing was a luminary in tumor pathology and was well versed in the clinical diagnosis and treatment of tumors. He opposed mutilating surgical procedures and was an advocate of radium and low-voltage x-ray therapy of cancers. Through his lectures, writings, and as a consultant, he influenced the way pathologists and clinicians diagnosed tumors and cared for cancer patients. Ewing advocated a multidisciplinary approach in cancer care, and directed in 1940 the first national seminar on the diagnosis and treatment of tumors of the breast. He demonstrated that large number of tumor cells in mitosis, cellular pleomophism, hypervascularity, and tumor necrosis are signs of increased malignancy.64, 65 Many of his redoubtable observations and thoughts are considered valid even today.

In 1931, Ewing's lectures on cancers were transcribed by his students and were printed as a monograph.67 Also, in 1931, the January 12 issue of Time magazine was dedicated to “Cancer Man Ewing,” and he was portrayed on the front cover as a formal homage in recognition of his many contributions to oncology. One can state without reservation that Ewing was the foremost tumor pathologist of the first half of the 20th century.

Pierre Masson (1880-1959), a French-Canadian neuropathologist turned tumor pathologist, in his book, Diagnostic de Laboratoire, which was published in 1923, introduced more new pathology terms than any other pathologists before his time.39 Masson was a prodigious writer. Among his many premier contributions to tumor pathology are: description of subcutaneous epithelioid sarcoma, intrahepatic bile duct carcinoma, adrenal paraganglioma, glomus tumor, myoepithelial tumor of the breast and rhabdomyosarcoma in peripheral nerve. He divided for the first time rhabdomyosarcomas into embryonal and pleomorphic, adult, forms. He explained in length his cogent theories on the genesis and pathomechanism of tumors.39 Masson's main tenet was that nevi and melanomas were of nerve origin.68 He identified the nerve sheath as the source of benign and malignant nerve tumors, or Schwannomas.39 He named carcinoid as an endocrine tumor69 and linked it to nerve hyperplasia.70 Two decades later, he advanced the theory that all intestinal carcinoids are potentially malignant neoplasms.

Albert C. Broders (1885-1964), a pioneer surgical pathologist at the Mayo Clinic in Rochester, Minnesota, was associate director of the Mayo laboratories from 1914. In 1920, Broders introduced an innovative numerical microscopic grading system for carcinomas of the lip,71 based on cellular differentiation on a scale of 1 to 4. A couple years later, he extended his grading method to cancers of other anatomic sites, and he reached the conclusion that tumors with the microscopic cellular morphology of carcinoma should be called carcinoma whether or not the cancer cells invaded beyond the basement membrane. He named noninvasive carcinomas as carcinoma in situ72 (Fig. 6). In the 1930s, Broders and his associates performed retrospective grading of soft tissue and bone sarcomas as well as breast carcinomas. By studying more than 4000 breast carcinomas, they were able to determine, by grading, the occurrence or nonoccurrence of axillary nodal metastasis.73 Broders's system of histologic grading was universally accepted and remains in use today. He was the first to demonstrate that the histologic grade of primary cancers is by far the most important, in addition to the size of the cancer and the depth of the invasion, in predicting outcome.

thumbnail image

Figure 6. Shown is the title page of Albert C. Broders's 1932 epoque-making article72 with the microscopic illustration of a squamous cell carcinoma in situ of the uterine cervix.

Download figure to PowerPoint

The roster of reported new malignant neoplastic entities is a long one. The most remarkable newly introduced terms that are still in use were: neurocytoma and neuroblastoma,74 hepatoma,75 chordoma,76 embryonal carcinoma,64 intraepidermal carcinoma,77 carcinosarcoma,64 medulloblastoma,78 dermatofibrosarcoma protuberans,79 oligodendroglioma,80 tubular carcinoma of the breast,81 oat cell carcinoma,82 arrhenoblastoma,83 reticuloendothelioma and histiocytoma,84 synovial sarcoma,85 comedocarcinoma,86 neurilemmoma,87 and mesonephroma ovarii.88

Memorable case reports and large series of cases were often published under the cooperation of pathologists, radiologists, and surgeons, which added much-needed credibility to the presented data. It is perhaps important to remember that many of the so-called first cases and series of cases were often reported by physicians who were not distinguished, and the authors are often forgotten. Some of the most remarkable first reports were: preinvasive carcinoma (carcinoma in situ) of the uterus,89 metastatic rhabdomyosarcoma,90 parosteal sarcoma,37 thymic tumors in association with myasthenia gravis,91 primitive neuroectodermal tumor,92 follicular lymphoma,93 oat cell carcinoma of the lung,94 malignant meningioma,95 microinvasive duct carcinoma of the breast,96 pleural mesothelioma,97 malignant melanoma of the eye,98 carcinoma of the bladder,99 primary lung carcinoma,100 biphasic and monophasic synovial sarcoma,101 chordoid tumor of the palm,102 extramammary Paget's disease,103 Ewing's sarcoma of soft tissues,104 and classification tumors of the testis.105

Many new and cogent classifications of cancers were introduced, but only a few achieved permanent acceptance. Ewing's classification of cancers lasted into the 1960s with little modification.64, 65 By studying the depth of invasion and the lymphatic spread of carcinoma of the rectum, Cuthbert Dukes (1890-1977), a London pathologist, classified the tumors into groups A, B, and C.106 According to this formidable design: A) The carcinoma was confined to the wall of the rectum, B) The carcinoma has progressed by direct spread to the perirectal tissues, and C) The carcinoma metastasized to perirectal lymph nodes (Fig. 7). Dukes extended his classification schema to carcinomas of the colon in the 1940s, and it remains in use to today to augur intestinal cancers. The prognosis of Hodgkin's disease was linked to histopathologic forms of the tumor. It was demonstrated that it made a significant difference whether the tumor was a paragranuloma, granuloma, or sarcoma.107

thumbnail image

Figure 7. Cuthbert Dukes in his 1935 article106 presented in Table 1 the 5-year survival of patients after surgery for rectal carcinoma with consideration of the extent of spread of the carcinoma.

Download figure to PowerPoint

From the first time cancer cells were seen with the microscope in 1838 on smears from scrapings of tumors,108 the cytologic examination was gradually extended to body fluids and secretions.109 Introduction of laboratory stains, intraoperative microscopic examination,110 and the diagnosis of tumors on smears made from aspirates64 contributed to the burgeoning practice of cytology. In 1928, 2 physicians, Aurel Babès (1886-1961), a gynecologist in Romania, and George Papanicolaou (1883-1962), an anatomist in New York, presented their techniques of obtaining cells by scraping from the cervix and the vagina of gynecologic patients. The article by Babès with microscopic photographs illustrating precancerous cells and cancer cells of the uterine cervix was published in Paris in the April 1928 issue of the La Presse Médicale111 (Fig. 8). Papanicolaou, in January of the same year, presented his illustrated lecture at an international conference, the Third Race Betterment Conference, in Detroit, Michigan.112 Although Babès' and Papanicolaou's analogous techniques were well thought out and auspicious, their method was not appreciated by the medical community, and the smear technique was not accepted for the detection of uterine cancers until the 1940s.113 In the interim, the aspiration smear technique was perfected,67 and Fred W. Stewart (1894-1991), an associate pathologist of James Ewing at the Memorial Hospital for Cancer and Allied Diseases, extended needle aspiration to tumors at all body sites.114 During the same period, the diagnostic cytology techniques and microscopic examination of body fluids and secretions became routine procedures. It was reported, for example, that in 68% of the carcinomas of the lung and larynx, the diagnosis of cancer was established by examination of the sputum.115

thumbnail image

Figure 8. Title page of Aurel Babès 1928 article111 with a photomicrograph of a uterine cervical smear shows malignant squamous epithelial cells and inflammatory cells.

Download figure to PowerPoint

From 1900 onward, surgery was developing special fields, and each subsequent decade added specialized knowledge to patient care to the extent that during the first half of the 20th century, the medical profession's zeitgeist was that radical surgical treatment was the best treatment for primary and metastatic cancers. Radical surgical procedures that were introduced in the late 1800s1 were perfected, and the tenacity of surgeons resulted in the decrease of operative mortality of cancer patients.116-119 Some of the most notable inventions and procedures that were put in routine use were: removal of bladder tumors by transurethral fulguration,120 diagnosis of cancer by laparoscopy and thoracoscopy,121 gastroscopy with an optical instrument equipped with a lamp at its tip,122 extended radical surgical procedure for tumors of the head and jaws,123 resection portion of the esophagus and reconstruction with a rubber tube,124 tracheobronchoscopy,125 extended retroperitoneal node dissection,126 hemipelvectomy,127 forequarter amputation,128 demonstration of the main lymphatics of the breast with collaterals to other sites129 (Fig. 9), trans-sternal thoracotomy,130 rectosigmoidoscopy with rigid scope using a lamp and mirror for illumination,131 technique of colostomy and the apparatus with rubber receptacle,132 uterine cervical biopsy with forceps,133 resection of the colon with excision of the lymph nodes,42 pulmonary resection for the treatment of metastatic tumors,134 technique of wide excision of cancers to prevent recurrence,135 interscapulo-thoracic resection,136 thoracotomy for metastatic carcinoma of the lung and mediastinum,137 transillumination to distinguish solid and cystic breast lesions,96 detection of uterine cervical carcinoma by painting the cervix with Lugol's iodine solution,138 pneumonectomy for primary carcinoma of the lung,139 peritoneoscopy,140 resection of carcinoma of the ampulla of Vater,141 modified pancreatoduodenectomy,142 segmental pneumonectomy,143 and surgical resection of metastasis to the liver.144

thumbnail image

Figure 9. Fitzwilliams's illustration from 1924 shows the lymphatics of the breast.129

Download figure to PowerPoint

Although the surgeons' raison d'etre was to perfect their operative techniques with intent of improving the survival of patients, they also spent considerable time on publishing their cases with end results, and they occasionally described newly discovered entities. The most splendid reports were: The origin of most primary lung carcinomas were intraoperatively traced to the major bronchi.145 Primary malignant melanoma of the rectum, an invariably fatal disease, was reported for the first time to originate at the pectinate line and to grow upward into the rectal ampulla.146 Three decades after American surgeon William Halsted (1852-1922) introduced his radical operation for breast cancer,1 he reported permanent lymphedema of the upper extremity after surgery in a large percentage of his patients.147 In 1922, it was found in a large series of patients that life expectancy following radical mastectomy depended on the size of the carcinoma and the extent of axillary spread of the carcinoma.148

In a series of 878 patients treated by mastectomy at the Johns Hopkins Hospital, Baltimore, Maryland, during a period of 42 years, it was reported that the postoperative mortality was gradually reduced to 6%, and the 3-year survival of patients increased to an unprecedented 52%.149 The 5-year survival rate of patients, who had carcinoma of the colon and rectum and had surgical resection, by different surgeons who were using different methods, ranged from 13% to 29%.42 Twenty-eight cases of a new entity, inflammatory mammary carcinoma, with invariably grave prognosis, was reported.150 Forty years after the first abdominal desmoid tumors were reported,1 the natural history of desmoid tumors of the abdominal wall was presented with review of 59 published cases. It was concluded that because 80% of the tumors occurred in women who have borne children, trauma plays role in the etiology of the growths and the treatment should involve early and complete removal with wide tumor-free margins.151 The clinical presentation, radiology, treatment, and prognosis of bone sarcomas were presented by pointing out that, on average, fewer than 15% of the patients were alive for 5 years.152 A new deadly entity, superior pulmonary sulcus tumor, was described with presentation of the characteristic clinical signs and symptoms and radiologic appearance.153 A total of 54% of the patients who were treated for primary carcinoma of the ovary were alive 3 or more years after surgery.154 In 1934, Joe V. Meigs (1892-1963), an American surgeon, as a follow-up to his earlier observation,1 in his book Tumors of the Female Pelvic Organs155 described a series of new gynecologic observations including ovarian tumors with ascites and hydrothorax that became known as Meigs' syndrome. Alan O. Whipple (1881-1963), a New York surgeon, introduced a new and radical procedure, pancreaticoduodenectomy and resection of peripancreatic lymph nodes and the spleen. The operation became known as the Whipple procedure,141 and it was described after careful observation that carcinoma of the pancreas is associated with deep venous thrombosis in 25% of the patients.156 A large series of patients had surgical resection of their chordoma with limited success.157 Carcinoma of the kidney was deemed a highly malignant neoplasm, and only 7% of the 127 patients who had nephrectomy lived 10 years.158 On the other hand, the outlook for patients with thyroid carcinoma was excellent. A total of 58% of the 774 patients who had surgery were alive 10 years after surgery.159 It is perhaps important to add that the improved survival of patients in the 1930s did not come about solely because of improved surgical techniques. Undoubtedly, after the discovery of penicillin160 and sulfanilamide,161 patients were protected against some of the intraoperative, perioperative, and postoperative bacterial infections, whereas this added protection was not available in the prior decades.

Harvey W. Cushing (1869-1939), an American neurosurgeon, contributed more to improving the diagnosis and surgical treatment of tumors of the brain, meninges, and spinal cord than any other surgeon. He, along with his associates, discovered several new entities,78, 80 but above all, he was a master surgeon who advanced surgical techniques by adoption of new anesthetic methods, electrocoagulation, electric suction, and surgical decompression. Cushing was stringent about the preoperative preparation of patients. He insisted that the patients must have thorough physical and x-ray examination, electroencephalography, and ventriculography. His expertise and skills have transformed brain surgery, which was previously a highly fatal procedure, into a comparatively safe operation, and by the 1930s, he reduced the surgical mortality to 11% and the postoperative mortality to 16%.162 Cushing's classification of brain tumors with consideration of histopathologic appearance allowed him to delineate the prognosis80 (Fig. 10). There is no doubt that Cushing was a consummate brain surgeon, and his work is regarded as the most important surgical achievement in the first half of the 20th century. Even a synoptic review would not be complete without mentioning that in 1932, Cushing reported pituitary basophilic adenoma-associated centripetal obesity, moon face, hypertension, and gonadal dysfunction.163 The pituitary endocrine tumor-induced disease is eponymically known as Cushing's disease. As an addendum, Cushing as a medical historian authored the biography of William Osler (1849-1919), his much-admired mentor. The book is enticing and won for him a Pulitzer Prize for literature in 1926.

thumbnail image

Figure 10. Shown is the title page of Percival Bailey's and Harvey Cushing's groundbreaking book, published in 1926.80

Download figure to PowerPoint

The penultimate portion of this review is on diagnostic radiology and radiation therapy. It is perhaps worth pointing out that amid all the advances in surgery, progress in radiologic diagnosis of tumors proceeded slowly, mainly due to the technical difficulties. Nevertheless, by 1908, fluoroscopy of the stomach, facilitated by the patient swallowing a suspension of bismuth, was adopted for radiologic diagnosis of gastric lesions,164 and 15 years later, barium enema was added for visualization of colonic tumors.132 Other groundbreaking techniques introduced were ventriculoscopy of the brain by using air,165 pneumocystography,166 transhepatic cholangiography,167 injection of radio-opaque oil (lipiodol),168 the use of thorium dioxide (Thorotrast) for visualizing the spleen,169 tomography,170 drinking of effervescent Vichy water for visualization of pancreatic tumors,171 and pyelography and cystography after injection of radio-opaque substance.172

It was recognized from the outset that accurate radiologic diagnosis depended on the technical know-how and expertise of the radiologists. The first radiologists were mostly surgeons who were eager to know what was hidden from them in the tissues and organs of the patients before they operated. It is interesting to note that bone tumors in animals were among the first tumors diagnosed by radiologic examination.173 The earliest remarkable diagnoses of malignant tumors in humans were: Ewing's sarcoma with the characteristic thickening of the periosteum,66 bone sarcomas with elevation of the periosteum at the edge of the tumor (Codman's triangle),174 primary carcinoma of the lung,175, 176 carcinoma of the colon,132 different types of bone sarcomas with clinical and pathologic correlation,152, 177 breast cancers with call for limited surgery and radium treatment,178 and carcinomas metastatic to bone with illustration of the skeletal distribution.179 In this latter article, the author listed breast carcinoma, carcinoma of the prostate, uterus, and thyroid as the most common primary neoplasms with metastases to bone. It was found disappointing that upon radiologic examination of the breast (mammography) of 142 asymptomatic patients, the differentiation between cystic tumors, solid benign tumors, and malignant neoplasms was not possible.180

Even though radiotherapy had its birth the year after Röntgen discovered x-rays,1 radiation therapy was still in the inchoate phase in the first decades of the 20th century. The majority of the problems were caused by the technical difficulties, setbacks in manufacturing, unsettled instrumentation, and the cost. Furthermore, it did not help that the progenitors of radiotherapy were physicians with diverse background and irresolute interest. At the beginning, it was a random decision in most cases whether x-rays or radium should be used.181, 182

However, after the 1920s, when radiology was recognized as a new medical specialty, for example by the American Medical Association, radiologists made concerted efforts to advance radiation treatment by selecting the best modality of therapy with attention to the size, location, and histological type and grade of the cancer. The majority of the earliest attempts in radiation therapy were made to treat the 2 most common and most dreaded cancers of women: breast cancer and uterine cervical cancer. For most of the breast cancers, treatment consisted of x-ray radiation67, 96, 149, 183, 184 (Fig. 11), whereas the majority of cervical cancers were treated by interstitial or endocavitary application of radium seeds (brachytherapy)133, 155, 185-189 (Fig. 12). In both cancers, the radiation was given either as palliative measure,188, 190 in inoperable cases, or it was delivered postoperatively to the primary site and regional lymph nodes.191-195 On rare occasions, the radiation was given prior to surgery to the tumor-bearing area.196 Some of the other first attempts at radiation therapy were treatment of carcinomas of the prostate,172, 197, 198 bladder,99, 172, 197 esophagus,199 thyroid,159, 200 pharynx and larynx,201, 202 rectum and anus,203 as well as metastases,179, 204 leukemia,205-207 Hodgkin's disease,107 non-Hodgkin's lymphoma,93 brain tumors,80 and sarcomas.152, 177, 208

thumbnail image

Figure 11. In William S. Handley's book,183 published in 1924, a room is shown equipped and ready for x-ray treatment.

Download figure to PowerPoint

thumbnail image

Figure 12. Photographs from Joe V. Meigs' book of 1934 show the results after radium treatment for carcinoma of the cervix.155

Download figure to PowerPoint

Culling of the results of radiation therapy was bordering on the impossible due to dearth of accurate information and the variation of techniques and the way partial and complete response as well as disease-free survival were defined. The variations in reporting were extreme from country to country and from institution to institution. Some of the treatment results reported were: complete response of skin cancers in 65% of the patients,182 limited success in the treatment of inoperable cervical cancers and successful treatment in operable cases,209, 210 a 5-year cure rate of 18% in advanced cervical cancers,211 a 30% cure rate with postoperative radiation of breast cancers,192 prolongation of life in the majority of metastatic cancers,179 very limited success in treating anal and rectal cancers due to inability to treat the metastatic nodes,203 and temporary results in some of the bone sarcomas64, 67, 152 and lymphomas.107 Although the cellular damage caused by radiation was fairly well understood and was credited to disintegration of the cytoplasm, destruction of the centriole, segmentation of the chromosomes, and destruction of the nuclear chromatin,182, 212 the reason for radioresistance was not clear beyond suggesting that the decrease of oxygenation and the blood supply was somehow involved.213 Because of proven radioresistance of the majority of cancers, surgery continued to hold primacy in treatment of cancer patients. The quintessential examples of exceptions to this rule were Ewing's sarcoma and Hodgkin's disease.

At the end of the 19th century, Paul Ehrlich (1854-1915), a German biochemist, introduced the concept that chemicals might be useful in the treatment of cancers.1 By the turn of the century, an endless number of chemicals were used as internal therapeutic agents, including alcohol, arsenic, jodoform, selenium, potassium chloride, osmium, pyoctanin, thallium, and thyroid extract.64, 214, 215 In 1919, Edward B. Krumbhaar (1882-1966), a US Army pathologist, was the first to notice that soldiers who survived for several days the poisoning by mustard gas during World War I developed profound leukopenia.216 Krumbhaar's observation on leukopenia received no attention for years, but a decade later, it was demonstrated in experimental and clinical studies that certain malignant tumors temporarily decreased in size when nitrogen mustard was administered. However, nitrogen mustard treatment of patients was proscribed due to extreme toxicity.217 Again, surgery continued to hold its lead in the treatment of cancer patients, and the therapeutic use of nitrogen mustard did not resurface until the 1940s.

With the exception of the vaccination attempts by William B. Coley (1862-1936)1 and the first clinical use of autologous tumor cell suspension,218 the potentials of the discoveries in immunology and immunotherapy remained almost completely unexplored prior to the 1940s. Some of the noteworthy reported observations and therapeutic attempts were: patients were given autologous or allogeneic tumor vaccine without therapeutic benefit,219, 220 alterations in the chromosomes of cells were deemed prerequisite to cancer,2 the lymphocytes and eosinophiles were identified to play an important role in immunity against the growth and spread of cancer,221-224 antigen–antibody coupling was viewed as a precondition to immunity,225 DNA in the cell was recognized to play critical role in immunity,226 and finally, advanced age was regarded as “cancer age” due to immune deficit.227

Adding all up, although the advances made in detection of cancer by clinical and radiologic examinations coupled with innovative radiation therapy and improved radical surgical techniques resulted in longer recurrence-free survival of the majority of cancer patients by the end of the 1930s,65 the overall survival showed little improvement. Likewise, the worldwide incidence of the most common cancers64, 65, 228 remained very much the same as it was in the first decades of the 20th century64, 229-231 (Fig. 13). The exceptions were increase in gastric carcinomas65 and lung carcinomas.57-59, 228 At the end of the 1930s, mortality due to cancer, according to the American Society for Control of Cancer, ranked second as the cause of death in the United States.65, 232 In a very revealing comparative study of cancers in Jews and non-Jews in Europe, a significant difference was reported in the incidence of breast, ovarian, intestinal, and uterine carcinomas.233 It was noted that breast, ovarian, and intestinal carcinomas were more common, and uterine carcinomas were less common in Jews than in non-Jews.

thumbnail image

Figure 13. Frederick V. Hoffman's 1915 illustration229 shows the international cancer mortality.

Download figure to PowerPoint

Parenthetically, the events in cancer research, diagnosis, and treatment of cancers were intimately associated with the founding of cancer research institutions and cancer hospitals. Some of the new bastions dedicated to cancer research and specialized care of cancer patients were the Radiumhemmet, Sweden (1910); the Netherlands Cancer Institute (1913); the Russian Radiology and Oncology Institute (1920); the French Institut du Cancer (1921); the Cancer Research Centre of India (1922); the Institut du Cancer at Louvain, Belgium (1925); the Belgian Centre Anticanceraux (1925); the Leningrad Institute of Oncology (1926); the Research Hospital of the New York State Institute for the Study of Malignant Disease (1931); the National Cancer Institute of the United States (1937); and the Institute of Cancer Research of the Royal Cancer Hospital, London, England (1939).

In addition, the nexus between newly established cancer registries and organizations furthered the commitment to early detection, diagnosis, and treatment of cancers. The most notable associations that were formed are: the American Association for Cancer Research (1907); the American Commission on Cancer (1912); the American Society for Control of Cancer (1913); the American Registry of Bone Sarcomas (1920); the French Association for the Study of Cancer (1920); the German Cancer Registry (1927); the Polish Anti-Cancer Society (1929); the International Union Against Cancer, or UICC (1933); the Connecticut Tumor Registry, United States (1935); the Tumor Registry of the Armed Forces Institute of Pathology, United States (1937); and the Cancer Registry of New York (1940).

It would be a remiss not to recognize Jacob Wolff (1861-1938), a German physician, for his exhaustive 4 volumes on the history of cancer,234 which were published in 1907 through 1928, and Cushman D. Haagensen (1900-1990), an American surgeon, for publishing in 1933 an annotated bibliography of cancer.235

It is perhaps a fitting conclusion that during the 3 decades covered in this narrative, more discoveries were made in the etiology, early detection, diagnosis, and therapy of cancers than were made in all prior centuries combined.1, 108, 236, 237 Looking back, it is apparent that despite the many advances that were made in the care of cancer patients (Table 1), the optimism of ardent surgeons and radiotherapists about the prospects for conquering cancer was an early and unrealistic claim. By contrast, pathologists, as the result of interaction with surgeons and other physicians who cared for cancer patients, emerged as dependable custodians of the old and newly discovered neoplastic entities, histopathologic classifications, and histologic grading of cancers, all of which were recognized as prerequisite for planning of the most appropriate therapy.

Table 1. Chronology of Discoveries, First Descriptions, New Terms, and Other Salient Events
YearMedical HistoryYearWorld History
1910Hepatoma, neuroblastoma and carcinoma in situ described. Transurethral fulguration of bladder tumors.1910Institut Océanographique de Monaco founded. Stravinsky's Firebird performed in Paris.
1911Laparoscopy, thoracoscopy, and gastroscopy introduced. Wertheim's hysterectomy popularized.1911Marie Curie receives her second Nobel Prize. Mona Lisa stolen from the Louvre.
1912Bowen's disease described. Extended radical neck dissection, and tumor vaccine introduced.1912Detection of protons and electrons. The Titanic sinks.
1913Hereditary cancers reported. Esophagectomy with plastic reconstruction.1913Neils Bohr formulates his theory of atoms.
1914Human cancer grown in tissue culture. Carcinoid indentified as neuroendocrine tumor. Parosteal sarcoma and the immunologic role of lymphocyte described. Tracheobronchoscopy introduced.1914The First World War begins. The Panama Canal opens.
1915Tar-cancer produced in animals. Squamous carcinoma linked to leukoplakia.1915German troops introduce nitrogen mustard gas.
1916Hemipelvectomy introduced.1916Ultrasound detects submarines.
1917Radiation therapy of prostate and bladder carcinomas.1917Communist revolution in Russia. British occupy Baghdad.
1918Carcinoma of stomach linked to gastric ulcer.1918Iceland becomes independent state.
1919Mustard gas causes leukopenia.1919Versailles peace conference.
1920Broder's histologic grading introduced1920Structure of Milky Way shown.
1921Ewing's sarcoma and postmastectomy lymphedema reported. Transhepatic cholangiography.1921Isotopes successfully separated. British Broadcasting Company is formed.
1922Nucleo-cytoplasmic ratio described. Forequarter amputation. Brachytherapy of uterine carcinomas.1922Self-winding wristwatch invented.
1923Rectosigmoidoscopy and barium enema.1923Hitler fails to take power in Germany.
1924Inflammatory breast carcinoma described. Abdominal desmoids linked to trauma. Leukemia treated with radiation.1924U.S. grants Cuba independence. The first winter Olympics are held.
1925Urethane decreased lymphocytes in animals. Jaagsiekte disease, medulloblastoma, follicular lymphoma, and Codman triangle described. Lyphoma treated with radiation. Colon resection with node dissection.1925The concept of genes introduced by the Russian Vavilov. Afrikaans becomes the official language of South Africa.
1926Tubular carcinoma and oligodendroglioma reported. Classification of brain tumors. Brain tumors irradiated.1926John Baird of Scotland invents television transmitter.
1927Soft tissue and bone sarcomas treated with radiation.1927Charles Lindbergh flies from New York to Paris.
1928Smear technique introduced for detection of cervical carcinoma. Colon carcinoma linked to polyposis. Smoking determined to cause cancer.1928The American Schick invents electric razor.
1929The Warburg effect defined. Thyroid carcinoma linked to goiter. Mesothorium causes osteosarcoma. X-ray radiation of breast carcinoma.1929Russian-American chemist Phoebus Levene discovers RNA and DNA.
1930Polycyclic hydrocarbons identified as carcinogens. Oat cell carcinoma described.1930France begins building the Maginot Line.
1931Hepatoma linked to cirrhosis. Microinvasive breast carcinoma reported. Limited breast surgery and radium treatment.1931Lawrence, American physicist, invents cyclotron. New York's Empire State Building opens.
1932Benzopyrene identified as carcinogen. Breast carcinoma induced by estrogen in animals. Miners' lung cancer caused by radioactive substances. Carcinoma in situ is named. Superior sulcus tumor described. Cancer is second leading cause of death in the United States.1932Antigen-antibody complex described. Positron and neutron discovered. Work begins on the Golden Gate Bridge in San Francisco.
1933Aspiration biopsy promoted as a diagnostic procedure. Schiller's test and tomography introduced. Pneumonectomy for lung cancer.1933Hitler becomes Chancellor of Germany. The first Nazi concentration camp established at Dachau.
1934Synovial sarcoma, comedocarcinoma, and the Meigs' syndrome described. Anorectal carcinoma irradiated.1934The S.S. Queen Mary is completed.
1935Lung cancer and mesothelioma linked to asbestosis. Dukes' classification and Whipple procedure introduced.1935The radar is built.
1936Biphasic and monophasic synovial sarcoma reported. Radioresistance is defined.1936DNA demonstrated in the cell nucleus.
1937Benzanthracenes identified as carcinogens. Classification of Hodgkin's disease.1937The first jet engine is built.
1938First mammography is performed.1938Xerography is developed.
1939Prostate carcinoma inhibited by estrogen. Segmental pneumonectomy1939The Second World War begins.
1940Pyelography and cystography introduced.1940Hemingway publishes For Whom the Bell Tolls.

FUNDING SOURCES

  1. Top of page
  2. Abstract
  3. FUNDING SOURCES
  4. REFERENCES

No specific funding was disclosed.

CONFLICT OF INTEREST DISCLOSURE

The authors made no disclosure.

REFERENCES

  1. Top of page
  2. Abstract
  3. FUNDING SOURCES
  4. REFERENCES
  • 1
    Hajdu SI. A note from history: landmarks in history of cancer, part 4. Cancer. 2012; 118: 4914-4928.
  • 2
    Boveri T. Zur Frage der Entwicklung maligner Tumoren. Jena, Germany: G. Fischer; 1914.
  • 3
    Marie P, Clunet J, Raulot-Lapointe G. Contribution a l'étude du développement des tumeurs malignes sur les ulcers de Roentgen. Bull Assoc Francaise Etude Cancer. 1910; 3: 404-426.
  • 4
    Carrel A, Burrows MT. Cultures de sarcome en dehors de l'organisme. C R Soc Biol. 1910; 69: 332-334.
  • 5
    Losee JR, Ebeling AH. The cultivation of human sarcomatous tissue in vitro. J Exp Med. 1914; 20: 140-148.
  • 6
    Carrel A. Essential characteristics of a malignant cell. J Am Med Assoc. 1925; 84: 157-158.
  • 7
    Carrel A, Lindbergh CA. The Culture of Organs. New York, NY: Hoebner; 1938.
  • 8
    Warburg OH, Negelein E. Ueber den Absorptionsspektrum des Atmungsferments. Biochem Z. 1929; 214: 64-100.
  • 9
    Fibiger J. Untersuchungen uber eine Nematode und deren Fahigkeit, etc. Zeitschr Krebsforsch. 1913; 13: 217-280.
  • 10
    Yamagiwa K, Ichikawa K. Experimentelle Studie uber die Pathogenese der Epithelialgeschwulste. Mitteil Med Facult Kaiser Univ Tokyo. 1915; 15: 295-344.
  • 11
    Hawkins JA, Murphy JB. The effect of ethyl urethane anesthesia on the acid-base equilibrium and cell contents of the blood. J Exp Med. 1925; 42: 609-618.
  • 12
    Berenblum I. The mechanism of carcinogenesis. A significance of carcinogenic action and related phenomena. Cancer Res. 1941; 1: 807-814.
  • 13
    Kennaway EL, Hieger I. Carcinogenic substances and their fluorescence spectra. Br Med J. 1930; 1: 1044-1046.
  • 14
    Cook JW, Hieger EL, Kennaway EL, Mayneord WV. The production of cancer by pure hydrocarbones. Proc R Soc. 1932; 3: 455-485.
  • 15
    Cook JW. Chemical compounds as carcinogenic agents. Am J Cancer. 1937; 29: 219-259.
  • 16
    Shear MJ. Development of liver tumors in pure strain mice following the injection of 2-amino-5-azotoluene. Am J Cancer. 1937; 29: 269-284.
  • 17
    Fieser LF. Carcinogenic activity of the cholanthrenes and other 1:2 benzanthracene derivatives. Am J Cancer. 1937; 29: 260-268.
  • 18
    Cook JW, Kennaway EL. Chemical compounds as carcinogenic agents. Am J Cancer. 1940; 39: 381-428.
  • 19
    Schram MWS. Index to the Literature of Experimental Cancer Research, 1900-1935. Philadelphia, PA: Donner Foundation; 1948.
  • 20
    Lacassagne AM. Apparition de cancers de la mamelle chez la souris male, etc. Compt Rend Acad Sci. 1932; 195: 630-632.
  • 21
    Burrows H. Pathological changes induced in the mamma by oestrogenic compounds. Br J Surg. 1935; 23: 191-213.
  • 22
    Loeb L. Estrogenic hormones and carcinogenesis. J Am Med Assoc. 1935; 104: 1597-1600.
  • 23
    Lacassagne A. Hormonal pathogenesis of adenocarcinoma of the breast. Am J Cancer. 1936; 27: 217-228.
  • 24
    Huggins CB, Masino MH, Eichelberger L, et al. Quantitative studies of prostate secretion. Characteristics of the normal secretion: The influence of thyroid, suprarenal and testis extirpation and androgen substitution on the prostatic output. J Exp Med. 1939; 70: 543-556.
  • 25
    Huggins CB, Hodges CV. Studies on prostate cancer. Cancer Res. 1941; 1: 293-297.
  • 26
    Shope RE. A filterable virus causing a tumor-like condition in rabbits and its relationship to virus myxomatosum. J Exp Med. 1932; 56: 803-822.
  • 27
    Cowdry EV. Studies on the etiology of Jaagsiekte. J Exp Med. 1925; 42: 323-334.
  • 28
    Bonne C. Morphologic resemblance of pulmonary adenomatosis (Jaagsiekte) in sheep and certain cases of cancer of the lung in man. Am J Cancer. 1939; 35: 491-501.
  • 29
    Hajdu SI. The story of bronchioloalveolar carcinoma. Ann Clin Lab Sci. 2005; 35: 336-338.
  • 30
    Rous P. The virus tumors and the tumor problem. Am J Cancer. 1936; 28: 233-272.
  • 31
    Ferguson AR. Associated bilharziasis and primary malignant disease of the urinary bladder, with observation on a series of forty cases. J Pathol Bacteriol. 1911; 16: 76-94.
  • 32
    Pirchan A, Sikl H. Cancer of the lung in the miners of Jachymov: report of cases observed. Am J Cancer. 1932; 16: 681-722.
  • 33
    Martland HS, Humphries RE. Osteogenic sarcoma in dial painters using luminous paint. Arch Pathol. 1929; 7: 406-417.
  • 34
    Wilensky AO, Thalhimer W. The etiological relationship of benign ulcer to carcinoma of the stomach. Ann Surg. 1918; 66: 215-225.
  • 35
    Hurst AF, Stewart MJ. Gastric and Duodenal Ulcer. London, UK: H. Milford; 1929.
  • 36
    Konjetzny GE. Der Magenkrebs. Stuttgart, Germany: F. Enke; 1938.
  • 37
    Hermann G, Morel CH. Precis d'Anatomie Pathologique. Paris, France: Doin; 1914.
  • 38
    Brophy TW. Oral Surgery. Philadelphia, PA: Blakiston's Son; 1915.
  • 39
    Masson P. Diagnostic de Laboratoire. Paris, France: A. Maloine et fils; 1923.
  • 40
    Neve EF. Kangri-burn cancer. Br Med J. 1923; 2: 1255-1256.
  • 41
    Treves N, Pack GT. The development of cancer in burn scars. An analysis and report of thirty-four cases. Surg Gynecol Obst. 1930; 51: 749-782.
  • 42
    Lynch JM, Felsen J. Tumors of the Colon and Rectum. New York, NY: P.B. Hoeber; 1925.
  • 43
    Gilford H. Tumors and Cancers. London, UK: Selwyn & Blount; 1925.
  • 44
    Franseen CC, Taylor GW. Arsenical keratoses and carcinomas. Am J Cancer. 1934; 22: 287-307.
  • 45
    Boveri T. The Origin of Malignant Tumors. Baltimore, MD: Williams and Wilkins; 1929.
  • 46
    Graham A. Nodular goiters: their relationship to neoplasia. Am J Surg. 1929; 7: 163-173.
  • 47
    Bargen JA. Chronic ulcerative colitis associated with malignant disease. Arch Surg. 1928; 17: 561-570.
  • 48
    McKenney DC. Multiple polyposis of the colon. J Am Med Assoc. 1936; 107: 1871-1876.
  • 49
    Hullsiek HE. Multiple polyposis of the colon. Surg Gynecol Obstet. 1928; 47: 346-356.
  • 50
    Coley BL, Sharp GS. Paget's disease: a predisposing factor to osteogenic sarcoma. Arch Surg. 1931; 23: 918-936.
  • 51
    Fried BM. Primary Carcinoma of the Lung. Baltimore, MD: Williams and Wilkins; 1932.
  • 52
    Gloyne SR. The presence of the asbestos fiber in the lesions of asbestos workers. Tubercle. 1929; 10: 404-407.
  • 53
    Lynch KM, Smith WA. Pulmonary asbestosis III: carcinoma of the lung in asbestos-silicosis. Am J Cancer. 1935; 24: 56-64.
  • 54
    Hajdu SI, Vadmal MS. The use of tobacco. Ann Clin Lab Sci. 2010; 40: 178-181.
  • 55
    Lombard HL, Doering CR. Cancer studies in Massachusetts. Habits, characteristics and environment of individuals with and without cancer. N Engl J Med. 1928; 198: 481-487.
  • 56
    Schachter M. Le cancer et le tabac. Prog Med. 1932; January: 157-163.
  • 57
    Hoffman FL. Cancer and smoking habits. In: Cancer, International Contribution to the Study of Cancer in Honor of James Ewing. Adair FE, editor. Philadelphia, PA: J.B. Lippincott; 1931: 50-67.
  • 58
    Muller FH. Tabachmissbrauch und Lungencarcinoma. Krebsforschung. 1939; 49: 57-85.
  • 59
    Ochsner A, DeBakey M. Carcinoma of the lung. Arch Surg. 1941; 42: 209-258.
  • 60
    Stanly WM. Isolation of crystalline protein possessing the properties of tobacco-mosaic virus. Science. 1935; 81: 644-645.
  • 61
    Warthin AS. Heredity with reference to carcinoma. Arch Intern Med. 1913; 12: 546-555.
  • 62
    Jüngling O. Polyposis intestini. Hereditäre Verhältnisse und Beziehungen zum Carcinom. Beitr Klin Chirurg. 1928; 143: 476-487.
  • 63
    Kimbrough RA. Coincident carcinoma of the ovary in twins. Am J Obstet Gynecol. 1929; 18: 148-149.
  • 64
    Ewing J. Neoplastic Diseases: A Text-Book on Tumors. Philadelphia, PA: W.B. Saunders Co; 1919.
  • 65
    Ewing J. Neoplastic Diseases.4th edition, Philadelphia, PA: W.B. Saunders Co; 1940.
  • 66
    Ewing J. Diffuse endothelioma of bone. Proc N Y Pathol Soc. 1921; 21: 17-24.
  • 67
    Ewing J. Causation, Diagnosis and Treatment of Cancer. Baltimore, MD: Williams & Wikins; 1931.
  • 68
    Masson P. Pigmented nevi; Nerve tumors. Ann Anat Pathol. 1926; 3: 417-453, 657-696.
  • 69
    Gosset A, Masson P. Tumeurs endocrines de l'appendice. Presse Med. 1914; 22: 237-240.
  • 70
    Masson P. Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Pathol. 1928; 4: 181-212.
  • 71
    Broders AC. Squamous cell cancer of the lip: a study of five hundred and thirty seven cases. J Am Med Assoc. 1920; 74: 656-664.
  • 72
    Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. J Am Med Assoc. 1932; 99: 1670-1674.
  • 73
    Broders AC. The microscopic grading of cancer. Surg Clin North Am. 1941; 21: 947-962.
  • 74
    Wright JH. Neurocytoma or neuroblastoma, a kind of tumor not generally recognized. J Exp Med. 1910; 12: 556-561.
  • 75
    Renon L, Geraudel E, Monier-Vinard R. L'hépatome, tumeur primitive du foie. Arch Med Exp Anat Pathol. 1910; 311-340.
  • 76
    Ribbert H. Das Karzinom des Menschen. Bonn, Germany: F. Cohen; 1911.
  • 77
    Bowen JT. Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis Syph. 1912; 30: 241-255.
  • 78
    Bailey P, Cushing HW. Medulloblastoma cerebelli. A common type of mid-cerebellar glioma of childhhod. Arch Neurol Psychiat. 1925; 14: 192-224.
  • 79
    Hoffman E. Über des knollentreibende Fibrosarkom der Haut (Dermatofibrosarcoma protuberans). Dermatologica. 1925; 43: 1-28.
  • 80
    Bailey P, Cushing HW. A classification of Tumors of the Glioma Group on a Histogenetic Basis with Correlation Study of Prognosis. Philadelphia, PA: J.B. Lippincott; 1926.
  • 81
    Atlas du Cancer. Paris, France: Association Française pour l'Étude du Cancer; 1926.
  • 82
    Duguid JB, Kennedy AM. Oat cell tumours of mediastinal glands. J Pathol Bacteriol. 1930; 33: 93-99.
    Direct Link:
  • 83
    Meyer R. Tubulare (testikulare) und solide Foramen des Andreiblastoma ovarii und ihre Beziehung zur Vermannlickung. Beitr Pathol Anat Allg Pathol. 1930; 84: 485-520.
  • 84
    Cellina M. Il reticulo-endotelioma (istiocitoma) primitive del fegato. Arch Anat Istol Patol. 1932; 3: 421-440.
  • 85
    Sabrazes J, Loubat E, de Grailly R, Magendie J. Synovialosarcomes. Gaz Hebdomad Sci Med. 1934; 48: 754-762.
  • 86
    Bloodgood JC. Comedocarcinoma (or comedo-adenoma) of the female breast. Am J Cancer. 1934; 22: 842-853.
  • 87
    Stout AP, Carson W. The peripheral manifestation of the specific nerve sheath tumor (neurilemmoma). Am J Cancer. 1935; 24: 751-796.
  • 88
    Schiller W. Mesonephroma ovarii. Am J Cancer. 1939; 35: 1-21.
  • 89
    Rubin IC. Pathological diagnosis of incipient carcinoma of uterus. Am J Obstet. 1910; 62: 668-676.
  • 90
    Burgess SM. Malignant rhabdomyoma with multiple metastases. J Med Res. 1914; 29: 447-456.
  • 91
    Bell ET. Tumors of the thymus in myasthenia gravis. J Nerv Mental Dis. 1917; 45: 130-143.
  • 92
    Stout AP. A tumor of the ulnar nerve. Proc N Y Pathol Soc. 1918; 18: 2-11.
  • 93
    Brill NE, Baehr G, Rosenthal N, et al. Generalized giant lymph follicle hyperplasia of lymph nodes and spleen, a hitherto undescribed type. J Am Med Assoc. 1925; 84: 668-671.
  • 94
    Barnard WG. The nature of the “oat-celled sarcoma” of the mediastinum. J Pathol. 1926; 29: 241-244.
    Direct Link:
  • 95
    Craig W. Malignant intracranial endotheliomata. Surg Gynecol Obstet. 1927; 45: 760-768.
  • 96
    Cheatle GL, Cutler M. Tumours of the Breast. London, UK: E. Arnold; 1931.
  • 97
    Klemperer P, Rabin CB. Primary neoplasms of the pleura. A report of 5 cases. Arch Pathol. 1931; 11: 385-412.
  • 98
    Callender GR. Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol. 1931; 36: 131-142.
  • 99
    Kretschmer HL. Cancer of the bladder. A study on 902 epithelial tumors of the bladder in the carcinoma registry of the American Urological Association. J Urol. 1934; 31: 423-472.
  • 100
    Kraft IA. Pathologische Anatomie und Histologie des primaren Lungenkrebses. Z Krebsforsch. 1934; 41: 51.
  • 101
    Knox LC. Synovial sarcoma. Am J Cancer. 1936; 28: 461-479.
  • 102
    Simard L-C. Tumour of the palm having the structure of a mixed tumour of the salivary glands. Am J Cancer. 1938; 33: 182-195.
  • 103
    Pinkus H, Gould SE. Extramammary Paget's disease and intraepidermal carcinoma. Arch Dermatol. 1939; 39: 479-502.
  • 104
    Potozky H, Freid JR. Ewing's tumor simulating sarcoma of soft tissue origin. Am J Cancer. 1939; 36: 1-11.
  • 105
    Malicow MM. Embryoma of testis: report of a case and a classification of neoplasms of the testis. J Urol. 1940; 44: 333-344.
  • 106
    Dukes C, Bussey HJ. Lymphatic spread in cancer of the rectum. Br J Surg. 1935; 24: 751-796.
  • 107
    Jackson H. The classification and prognosis of Hodgkin's disease and allied disorders. Surg Gynecol Obstet. 1937; 64: 465-467.
  • 108
    Hajdu SI. A note from history: landmarks in history of cancer, part 3. Cancer. 2012; 118: 1155-1168.
  • 109
    Hajdu SI. Cytology from antiquity to Papanicolaou. Acta Cytol. 1977; 21: 668-676.
  • 110
    Shaw EH. The immediate microscopic diagnosis of tumours at the time of operation. Lancet. September 24, 1910.
  • 111
    Babès A. Diagnostic du cancer du col utérin par les frottis. La Presse Med. 1928; 6: 451-454.
  • 112
    Papanicolaou GN. New cancer diagnosis. Proceedings of the Third Race Betterment Conference, January 2-6, 1928; pp 528-534.
  • 113
    Hajdu SI. Foundation of diagnostic cytology. Ann Clin Lab Sci. 2008; 38: 296-299.
  • 114
    Stewart FW. The diagnosis of tumors by aspiration. Am J Pathol. 1933; 9: 801-812.
  • 115
    Dudgeon LS, Wrigley CH. On the demonstration of particles of malignant growth in the sputum by means of the wet film method. J Laryngol Otol. 1935; 50: 752-763.
  • 116
    Miles WE. A method of performing abdomino-perineal excision for carcinoma of the rectum and the terminal portion of the pelvic colon. Lancet. 1908; 2: 1812-1813.
  • 117
    Jackson JN. Radical operation in mammary cancer. J Am Med Assoc. 1910; 54: 178-185.
  • 118
    Wertheim E. Die erweiterte abdominal Operation bei Carcinoma Colli Uteri. Berlin, Germany: Urban & Schwarzenberg; 1911.
  • 119
    Squier JB. Suprapubic intra-urethral enucleation of prostate. Boston Med Surg J. 1911; 164: 911-917.
  • 120
    Beer E. Removal of neoplasms of the urinary bladder. A new method of employing high-frequency current through a catheterizing cystoscope. J Am Med Assoc. 1910; 54: 1768-1769.
  • 121
    Jacobaeus HC. Kurze Uebersicht uber meine Erfahrungen mit der Laparo-thorakoskopie. Munch Med Wochenschr. 1911; 58: 2017-2919.
  • 122
    Elsner H. Die Gastroscopie. Leipzig, Germany: G. Thieme; 1911.
  • 123
    Scudder CL. Tumors of the Jaws. Philadelphia, PA: W.B. Saunders; 1912.
  • 124
    Torek F. The first successful case of resection of the esophagus for carcinoma. Surg Gynecol Obstet. 1913; 16: 614-617.
  • 125
    Mann MG. Lehrbuch der Tracheobronchoscopie. Wurzburg, Germany: C. Kabitzsch; 1914.
  • 126
    Hinman F. The operative treatment of tumor of the testicle. J Am Med Assoc. 1914; 63: 2009-2015.
  • 127
    Pringle H. The interpelvic-abdominal amputation. Br J Surg. 1916; 4: 283-296.
    Direct Link:
  • 128
    Littlewood H. Amputation at the shoulder and at the hip. Br Med J. 1922; 1: 381-383.
  • 129
    Fitzwilliams D. Carcinoma of the breast and its method of spread. Br J Surg. 1924; 12: 650-662.
    Direct Link:
  • 130
    Dunhill TP. Removal of intrathoracic tumours by trans-sternal route. Br J Surg. 1922; 10: 4-14.
  • 131
    Pennington JR. A Treatise on the Diseases and Injuries of the Rectum, Anus and Pelvic Colon. Philadelphia, PA: P. Blakiston; 1923.
  • 132
    Gant SG. Diseases of the Rectum, Anus and Colon. Philadelphia, PA: W.B. Saunders; 1923.
  • 133
    Faure JL. Cancer de l'Uterus. Paris, France: G. Doin; 1925.
  • 134
    Divis G. Ein Beitrag zur operative Behandlung der Lungengeschwulste. Acta Chir Scand. 1927; 62: 329-341.
  • 135
    Semken GH. Cancer as a specialty. Surg Gynecol Obstet. 1927; 44: 281-298.
  • 136
    Lindberg BE. Interscapulo-thoracic resection for malignant tumors of the shoulder joint region. J Bone Joint Surg. 1928; 10: 344-349.
  • 137
    Torek F. Removal of metastatic carcinoma of the lung and mediastinum. Arch Surg. 1930; 21: 1416-1421.
  • 138
    Schiller WB. Early diagnosis of carcinoma of the cervix. Surg Gynecol Obstet. 1933; 66: 210-220.
  • 139
    Graham EA, Singer JJ. Successful removal of entire lung for carcinoma of the bronchus. J Am Med Assoc. 1933; 101: 1371-1374.
  • 140
    Ruddock JC. Peritoneoscopy. West J Surg Obstet Gynecol. 1934; 42: 392-394.
  • 141
    Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg. 1935; 102: 763-779.
  • 142
    Brunschwig A. Resection of the head of the pancreas and duodenum for carcinoma —pancreaticoduodenectomy. Surg Gynecol Obstet. 1937; 65: 681-684.
  • 143
    Churchill ED, Belsey R. Segmental pneumonectomy in bronchiectasis. Ann Surg. 1939; 109: 481-499.
  • 144
    Catell RB. Successful removal of liver metastasis from a carcinoma of the rectum. Lahey Clinic Bull. 1940; 2: 7-10.
  • 145
    Adler I. Primary Malignant Growths of the Lung and Bronchi. New York, NY: Longmans, Green & Co; 1912.
  • 146
    Chalier A, Bonnett P. Les tumeurs melaniques primities du rectum. Rev Chir. 1913; 47: 64-103.
  • 147
    Halsted WS. Swelling of the arm after operations for cancer of the breast: elephantiasis chirurgica; its cause and prevention. Bull Johns Hopkins Hosp. 1921; 32: 309-313.
  • 148
    Sistruk WE, MacCarty WC. Life expectancy following radical amputation for carcinoma of the breast: a clinical and pathologic study of 218 cases. Ann Surg. 1922; 75: 61-69.
  • 149
    Lewis D, Rienhoff WF. A study of the results of operations for cure of cancer of the breast performed at Johns Hopkins Hospital from 1889 to 1931. Ann Surg. 1932; 95: 336-400.
  • 150
    Lee BJ, Tannenbaum NE. Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol Obstet. 1924; 39: 580-595.
  • 151
    Stewart MJ, Mouat TB. Fibroma of the abdominal wall. Br J Surg. 1924; 12: 355-377.
  • 152
    Geschickter CF, Copland MM. Tumors of Bone. New York, NY: Am J Cancer; 1931.
  • 153
    Pancoast HK. Superior pulmonary sulcus tumor: Tumor characterized by pain, Horner's syndrome, destruction of bone and atrophy of hand muscle. J Am Med Assoc. 1932; 99: 1391-1396.
  • 154
    Norris CC, Murphy DP. Malignant ovarian neoplasms, with a report of the end-results in a series of 93 cases. Am J Obstet Gynecol. 1932; 23: 833-837.
  • 155
    Meigs JV. Tumors of the Female Pelvic Organs. New York, NY: Macmillan; 1934.
  • 156
    Sproul EE. Carcinoma and venous thrombosis: The frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer. 1938; 34: 566-585.
  • 157
    Mabrey BE. Chordoma: a study of 150 cases. Am J Cancer. 1935; 25: 501-517.
  • 158
    Mintz ER, Gaul EA. Kidney tumors; some causes of poor end results. N Y State J Med. 1939; 39: 1405-1411.
  • 159
    Pemberton J de J. Malignant lesions of the thyroid gland; a review of 774 cases. Surg Gynecol Obstet. 1939; 69: 417-430.
  • 160
    Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol. 1929; 10: 226-236.
  • 161
    Domagk G. Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Dtsch Med Wochenschr. 1935; 61: 250-253.
  • 162
    Cushing HW. Intracranial Tumours. Notes upon a Series of Two Thousand Verified Cases with Surgical Mortality Percentages Pertaining Thereto. Springfield, IL: Charles Thomas; 1932.
  • 163
    Cushing HW. The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp. 1932; 50: 137-195.
  • 164
    Holzknecht G, Jonas S. Die radiologische Diagnostik der intra- und extraventricularen Tumoren und ihre spezielle Verwertung zur Fruhdiagnose des Magencarcinoms. Wien, Austria: M. Perles; 1908.
  • 165
    Dandy WE. Ventriculography following the injection of air into the cerebral ventricules. Ann Surg. 1918; 68: 5-11.
  • 166
    Pfahler GE. The injection of air for the Roentgen diagnosis of tumors of the bladder. Am J Roentgenol. 1919; 6: 371-375.
  • 167
    Burckhardt H, Muller W. Versuche uber die Punktion der Gallenblase und ihre Röntgendarstellung. Dtsch Z Chir. 1921; 162: 168-197.
  • 168
    Sicard JA, Forestier J. Method radiographic d'exploration de la cavite epidural par le lipiodol. Rev Neurol. 1921; 28: 1264-1266.
  • 169
    Oka M. Eine neue Methode zur rontgenologischen Darstellung der Miltz. Fortschr Rontgenstr. 1929; 40: 497-501.
  • 170
    Bartelink DL. Rontgenschnitte. Forschr Rontgenstr. 1933; 47: 399-407.
  • 171
    Engel A, Lyshholm E. A new roentgenological method of pancreas examination and its practical results. Acta Radiol. 1934; 15: 635-651.
  • 172
    Lowsley OS, Kirwin TJ. Clinical Urology. Baltimore, MD: Williams & Wilkins; 1940.
  • 173
    Woglom WH. Studies in Cancer and Allied Subjects. New York, NY: Columbia University Press; 1913.
  • 174
    Codman EA. Bone Sarcoma, an Interpretation of the Nomenclature Used by the Committee on the Registry of Bone Sarcoma of the American College of Surgeons. New York, NY: P.B. Hoebner; 1925.
  • 175
    Holmes GW, Ruggles HE. Roentgen Interpretation: A Manual for Students and Practitioners. Philadelphia, PA: Lea & Febiger; 1921.
  • 176
    Pancoast HK. Importance of careful roentgen-ray investigation of apical chest tumors. J Am Med Assoc. 1924; 83: 1407-1411.
  • 177
    Kolodny A. Bone sarcoma; primary malignant tumors of bone and giant cell sarcoma. Surg Gynecol Obstet. 1927; 44: 1-214.
  • 178
    Seabold PS. Roentgenographic diagnosis of diseases of the breast. Surg Gynecol Obstet. 1931; 53: 461-468.
  • 179
    Matheny-Cornat R. Le diagnostic radiographique et le traitement des metastases osseuses. Arch Electric Med. 1932; 40: 97-117.
  • 180
    Gershon-Cohen J, Strickler A. Roentgenologic examination of the normal breast. Am J Roentgenol. 1938; 40: 189-201.
  • 181
    Wickhan L, Degrais P. Radium Therapy. New York, NY: Funk & Wagnalls; 1910.
  • 182
    Colwell HA, Russ S. Radium, X Rays and the Living Cell. London, UK: G. Bell and Sons; 1915.
  • 183
    Handly WS. Cancer Research at the Middlesex Hospital. London, UK: Middlesex Hospital Press; 1924.
  • 184
    Hutchison RG. Radiation therapy in carcinoma of the breast. Surg Gynecol Obstet. 1936; 62: 653-664.
  • 185
    Pichevin A. La lute contre le cancer d'uterus. J Med Paris. 1912; 31: 151-153.
  • 186
    Degrais P. Radium therapie du cancer du col de l'uterus. Ann Gynecol Obstet. 1915; 22: 298.
  • 187
    Bailey H, Quimbley E. The use of radium in cancer of the female generative organs. Am J Obstet Gynecol. 1922; 3: 117-133.
  • 188
    Regaud C. Consideration sur la radiotherapie des cancers cervico-uterus d'apres l'experience et les resultats acquis a L'Institute du Radium des Paris. Radiophys Radiother. 1934; 3: 155-170.
  • 189
    Heyman J. The so-called Stockholm method and the results of treatment of uterine cancer at the Radiumhemmet. Acta Radiol. 1935; 16: 129-148.
  • 190
    Lee BJ. Results of treatment by radiation of primary inoperable carcinoma of the breast. Ann Surg. 1922; 76: 359-385.
  • 191
    Anschultz AW. Uber die postoperative Bestrahlung des Mammacarcinomas. Beitr Klin Chir. 1927; 139: 25-27.
  • 192
    Mayer L. Traitement radio-chirurgical de cancer du sein. Resultats eloignes. Assoc Franc Chir. 1931; 40: 353-361.
  • 193
    Taussing FJ. Iliac lymphadenectomy with irradiation in the treatment of cancer of the cervix. Am J Obstet Gynec. 1934; 28: 650-667.
  • 194
    Grace E, Mortrier W. Simple mastectomy with x-ray in treatment of cancer of the breast. N Y State J Med. 1936; 36: 701-704.
  • 195
    Borak J. Treatment of carcinoma of the breast by extirpation of the tumor and Roentgen irradiation. Radiology. 1936; 27: 33-35.
  • 196
    Quick D. Pre-operative and post-operative X-ray in carcinoma of the breast. Am J Roentgenol. 1920; 7: 597-601.
  • 197
    Young YH. Use of radium in cancer of the prostate and bladder. J Am Med Assoc. 1917; 68: 1174-1177.
  • 198
    Barringer BS. The treatment of prostatic carcinoma. Am J Roentgenol Radium Ther Nucl Med. 1937; 37: 49-52.
  • 199
    Guisez J. Plusieurs cas du cancers de l'oesophage traits avec success par la radium therapie. Bull Mem Soc Chir Paris. 1930; 22: 751-760.
  • 200
    Haagensen CD. Cancer of the thyroid: its radiosensitivity. Am J Cancer. 1931; 15: 2063-2105.
  • 201
    New GB, Fletcher E. Selection of treatment for carcinoma of the larynx. J Am Med Assoc. 1932; 99: 1754-1758.
  • 202
    Coutard H. Roentgentherapie des epitheliomas de la region amygdalienne, de l'hypopharynx et du larynx au cours des annees 1920 et 1926. Radiophysiol Radiother. 1932; 2: 541-575.
  • 203
    Regaud C. Traitment des epitheliomas du rectum et d'anus a l'Institut du Radium de l'Universite de Paris. Radiophysiol Radiother. 1934; 3: 429-439.
  • 204
    Willis RA. The Spread of Tumors in the Human Body. London, UK: J & A Churchill; 1934.
  • 205
    Minot GR, Buckman TE, Isaacs R. Chronic myelogenous leukemia: age incidence, duration, and benefit derived from irradiation. J Am Med Assoc. 1924; 82: 1489-1494.
  • 206
    Dale T. Total Roentgen irradiation of chronic leukemia. Acta Radiol. 1938; 19: 539-544.
  • 207
    Forkner CE. Leukemia and Allied Disorders. New York, NY: Macmillan; 1938.
  • 208
    Stout AP. Human Cancer. Philadelphia: Lea & Febiger; 1932.
  • 209
    Heyman J. Final results in the treatment of carcinoma of the uterine cervix at the “Radiumhemmet” Stockholm. Surg Gynecol Obstet. 1925; 40: 161-164.
  • 210
    Regaud C. Comparaison des valeurs curative de l'hysterectomie et des methods radiotherapiques dans le traitement des epitheliomas cervico-uterins du premier degree. Bull Acad Med. 1932; 107: 611-625.
  • 211
    Keene FE, Kimbrough RA. End-results of radium therapy in carcinoma of the cervix. Am J Obstet Gynecol. 1932; 23: 838-842.
  • 212
    Lacassagne A. Le problem des quanta en radiobiologie. Radiophys Radiother. 1934; 3: 215-234.
  • 213
    Mottram JC. A factor of importance in the radio sensitivity of tumours. Br J Radiol. 1936; 9: 606-614.
  • 214
    Behla R. Die Carcinomlitteratur. Berlin, Germany: R. Schoetz; 1901.
  • 215
    Hajdu SI. 2000 years of chemotherapy of tumors. Cancer. 2005; 103: 1097-1102.
  • 216
    Krumbhaar EB. Role of the blood and the bone marrow in certain forms of gas poisoning. J Am Med Assoc. 1919; 72: 39-41.
  • 217
    Adair FE, Bagg HJ. Experimental and clinical studies on the treatment of cancer by dichlorethylsulphide (mustard gas). Ann Surg. 1931; 93: 190-199.
  • 218
    Von Leyden VE, Blumenthal F. Vorlautige mittheilungen uber einige ergebnisse der Krebsforschung. Dtsch Med Wochenschr. 1902; 28: 637-649.
  • 219
    Coca AF, Dorrance GM, Lebredo MG. “Vaccination” in cancer. A report of the results of the vaccination therapy as applied in seventy-nine cases of human cancer. J Immun Exp Ther. 1912; 13: 543-551.
  • 220
    Vaughan JW. Cancer vaccine and anticancer globulin as an aid in the surgical treatment of malignancy. J Am Med Assoc. 1914; 63: 1258-1263.
  • 221
    Duval R. Processus histologique de la defense spontanee de l'organisme contra le cancer. Ann Med. 1914; 1: 75-101.
  • 222
    Bristol LD. The relation of the lymphocytes to cancer. J Am Med Assoc. 1919; 72: 1048-1050.
  • 223
    Sokoloff B. The nucleo-cytoplasmic ratio and cancer. J Cancer Res. 1922; 7: 395-415.
  • 224
    Kettle EH. The Pathology of Tumours. New York, NY: P.B. Hoebner; 1916.
  • 225
    Marrack JR. The Chemistry of Antigens and Antibodies. Special Report 194. London, UK: Medical Research Council; 1934.
  • 226
    Casperson T. Uber den chemischen Aufbau der Structuren des Zellkernes. Skand Arch Physiol. 1936; 73: 1-151.
  • 227
    Pack GT, LeFevre RG. The age and sex distribution and incidence of neoplastic diseases at the Memorial Hospital, New York City, with comments on “cancer age”. J Cancer Res. 1930; 14: 167-294.
  • 228
    Peters W. Uber des Lungencarcinom. Z Krebsforsch. 1932; 37: 587-635.
  • 229
    Hoffman FL. The Mortality from Cancer Throughout the World. Newark, NJ: Prudential Press; 1915.
  • 230
    Bainbridge WS, Hertoghe E. Le Problème du Cancer. Louvain, Belgium: Univ Press; 1922.
  • 231
    Mayo WJ. Mortality from Cancer in the United States for the Period 1900-1913. Chicago: American Medical Association; 1915.
  • 232
    Haggard HW. The Lame, the Halt, and the Blind. New York, NY: Harper Brothers; 1932.
  • 233
    Sorsby M. Cancer and Race. London, UK: Bale & Danielsson; 1931.
  • 234
    Wolff J. Die Lehre von der Krebskrankheit von den altesten Zeiten bis zur Gegenwart. 4 vols. Jena, Germany: Fischer; 1907-1928.
  • 235
    Haagensen CD. An exhibit of important books, papers, and memorabilia illustrating the evolution of the knowledge of cancer. Am J Cancer. 1933; 18: 42-126.
  • 236
    Hajdu SI. A note from history: landmarks in history of cancer, part 1. Cancer. 2011; 117: 1097-1102.
  • 237
    Hajdu SI. A note from history: landmarks in history of cancer, part 2. Cancer. 2011; 117: 2811-2820.